Method and compositions for controlling pain, depression and sedation
Patent 4596807 Issued on June 24, 1986. Estimated Expiration Date: 
July 16, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
July 16, 2005. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorAssigneeApplicationNo. 06/755367 filed on 07/16/1985US Classes:514/277, Hetero ring is six-membered consisting of one nitrogen and five carbon atoms514/253.04, Bicyclo ring having the additional six-membered nitrogen hetero ring as one of the cyclos514/419, C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen)514/474Ascorbic acid or derivative (e.g., vitamin C, etc.)ExaminersPrimary: Friedman, Stanley J.Attorney, Agent or FirmInternational ClassA61K 31/495 (20060101)AbstractCompositions are disclosed for controlling pain, depression, and sedation. The compositions comprise a serotonin precursor such as L-tryptophan or L-5-hydroxytryptophan in combination with a serotonin-specific reuptake inhibitor such as trazodone. In a preferred embodiment, the compositions are coadministered with a narcotic, the composition substantially potentiating the analgesic effect of the narcotic.Other References
Field of SearchC=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen)Hetero ring is six-membered consisting of one nitrogen and five carbon atoms Ascorbic acid or derivative (e.g., vitamin C, etc.) | |
